5. Reconstruction of craniofacial defects with bone-marrow-coated Polycaprolactone
scaffolds, Craniofacial Surgery, 2001, 9:109-111.
6. Fused deposition modeling of novel scaffold architectures for tissue engineering
applications, Biomaterials, 23 (2002): 1169-1185.
7. Induction of ectopic bone formation by using human
periosteal cells in combination with a novel scaffold technology,
Cell Transplantation, 11 (2002): 125-138.
8. Application of a X-ray microscopy technique to evaluate
tissue engineered bone-scaffold constructs, Mat Sci and
Eng: C (Special Issue on Biomaterials and Tissue Engineering):
20 (2002): 9-17.
9. Tissue engineering challenges and issues –
the Asian perspective, Tissue Engineering, 9
(Sup 1) (2003): S1-S3.
10. Scaffold design and in vitro study of osteochondral
co-culture in a 3D porous polycaprolactone scaffold fabricated
by fused fused deposition modelling, Tissue Engineering, 9 (Sup 1) (2003): S103-S112.
11. In vivo efficacy of bone-marrow-coated polycaprolactone
scaffolds for the reconstruction of orbital defects in the
pig, J Biomed Mats Res. Part B-Appl Biomat, 66B
(2003):574-580.
12. Repair of Calvarial Defects with Customised Tissue-Engineered
Bone Grafts. Part I: Evaluation of Osteogenesis in a 3D
Culture System, Tissue Engineering 9 (Sup
1) (2003): S113-S126.
13. Repair of Calvarial Defects with Customised Tissue-Engineered
Bone Grafts. Part II: Evaluation of cellular efficiency
and efficacy in vivo, Tissue Engineering 9
(Sup 1) (2003): S127-S139.
14. In vivo efficacy of bone-marrow-coated polycaprolactone
scaffolds for the reconstruction of orbital defects in the
pig, J Biomed Mats Res. Part B-Appl Biomat, 66B
(2003):574-580.
15. Asian Innovation Awards: The Winners 2004, Far Eastern Economic Review,
October 21, (2004):36.
16. Healing Heads, Far Eastern Economic Review, October 21, (2004):28-39.
18. Singapore team strikes gold for innovation, The Straits Times, Wed, Oct 13, 2004.
19. The effect of rhBMP-2 on canine osteoblasts seeded
onto 3D bioactive polycaprolactone scaffolds, Biomaterials,
25 (2004):5499-5506.
20. Analysis of 3D bone ingrowth into polymer scaffolds via micro-computed tomography imaging,
Biomaterials, 25 (2004): 4947-4954
22. Novel PCL-based honeycomb scaffolds as drug delivery
systems for rhBMP-2, Biomaterials, 26 (2005):
3739-3748
23. An evaluation of PCL-TCP composites as delivery
systems for platelet-rich plasma. Journal of Controlled
Release; 107 (2005): 330-342.
24. Flow modelling within a scaffold under the influence
of uni-axial and bi-axial bioreactor rotation, Journal of
Biotechnology, 119 (2005): 181–196
25. Osteogenic differentiation of mesenchymal progenitor
cells in computer designed fibrin-polymer-ceramic scaffolds
manufactured by fused deposition modeling J. Mats Sci-Mats
Med, 16 (2005):807-819.
26. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem
cells in a rabbit model, Tissue Engineering, 16 (2006):1539-1551.
27. Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits, Biomaterials,27 (2006): 1071-1080
28. Cranioplasty after trephination using a novel biodegradable burr hole cover: Technical case report, J Neurosurgery, 58 Sup 1 (2006): 176-179.
29. In vitro degradation of novel bioactive polycaprolactone-20% tricalcium phosphate composite scaffolds for bone engineering, Mats Sci and Eng, C,27 (2007): 293-298.
30. Comparison of the degradation of polycaprilactone and polycaprolactone-(beta-tricalcium phosphate) scaffolds in alkaline medium, Polym Int.,56 (2007):718-728
31. Polycaprolactone-20% Tricalcium Phosphate Scaffolds in Combination With Platelet-Rich Plasma for the Treatment of Critical-Sized Defects of the Mandible: A Pilot Study, J Oral & Max Surgery 65 (2007): 2195-2205.
32. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair, J Biomed Mats Res. Part A, 81A (2007): 888-899.
33. Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts, Biomaterials, 28 (2007): 814-824.
34. The degradation profile of novel, bioresorbable PCL-TCP scaffolds: An in vitro and in vivo study, J Biomedical Matls. Res. Part A, 84A (2008):208-218.
35. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions, Biomed. Mater. (UK) 3 (2008):1-15.
36. Customizing the Degradation and Load-Bearing Profile of 3D Polycaprolactone-Tricalcium Phosphate Scaffolds Under Enzymatic and Hydrolytic Conditions. J Biomed Mater Res.;87B (2008):562-569.
37. Biological performance of a polycaprolactone-based scaffold used as fusion cage device in a large animal model of spinal reconstructive surgery, Biomaterials, 30 (2009): 5086-5093
38. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2, Biomaterials, 30 (2009): 2479-2488.
39. Mandibular defect reconstruction using 3D PCL scaffold in combination with PRP and rhBMP-2: De novo synthesis of bone in a single case, Tissue Engineering, Part A, 15 (2009):493-499
40. Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res.;90A(2009):906-919
41. Use of Osteoplug polycaprolactone implants as novel burr-hole covers. Singapore Med J.;50 (2009):777-780
42. Patent - World Wide (PCT (WO 2010/044758 A1)) - Resorbable scaffolds for bone repair and long bone tissue engineering, Priority
filing: 17th October 2008
43. A biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone tissue engineering, Biomaterials,30 (2009): 2694-2704.
45. Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng Part B Rev. 2010 Feb;16 (1):93-104.
46. The evaluation of a biphasic osteochondral implant coupled with an electrospun membrane in a large animal model. Tissue Eng Part A. 2010 Apr, 16 (4):1123-41.
47. The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials. 2010 Jan; 31 (1):38-47.
48. Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds. Biomaterials. 2010 Nov;.31 (31):7960-70.
49. Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs. Yonsei Med J. 2009 Dec 31; 50 (6):825-31.
50. Surface modification of PCL-TCP scaffolds in rabbit calvaria defects: Evaluation of scaffold degradation profile, biomechanical properties and bone healing patterns. J Biomed Mater Res A. 2010 Jun 15; 93 (4):1358-67.
51. Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials. 2010 Feb; 31 (4):608-20.
52. Porcine bone marrow stromal cell differentiation on heparin-adsorbed poly(e-caprolactone)-tricalcium phosphate-collagen scaffolds. Acta Biomater. 2009 Nov; 5 (9):3305-15.
53. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng. 2007 Nov; 24 (5):489-95.
54. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells. 2009 Jan; 27 (1):126-37.
55. Surface modification of PCL-TCP scaffolds improve interfacial mechanical interlock and enhance early bone formation: an in vitro and in vivo characterization. J Biomed Mater Res A. 2010 Jan; 92 (1):311-21.
56. The evaluation of a biphasic osteochondral implant coupled with an electrospun membrane in a large animal model. Tissue Eng Part A. 2010 Apr; 16 (4):1123-41.
57. The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials. 2010 Jan; 31 (1):38-47.
58. Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds. Biomaterials. 2011 Jan; 32 (1):279-287.
59. The Effect of Platelet Rich Plasma on Osteogenesis in a Long Bone Segmental Defect: Is the Platelet Rich Plasma Effective for Bone Reconstruction?, Tissue Engineering and Regenerative Medicine, 7 (2010): 395-400.
60. Beyond Cell Capture: Antibody Conjugation Improves Hemocompatibility for Vascular Tissue Engineering Applications, Tissue Engineering, Part A, 16 (2010): 2485-2495.
61. A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering, Biomaterials, 31 (2010):8684-8695.
62. High tibial osteotomy using polycaprolactone-tricalcium phosphate polymer wedge in a micro pig model, Journal of Bone and Joint Surgery - British Volume, 93-B (2011): 120-125.
63. Building a better body, The Straits Times, Sat, Jan 13, 2011.
65. Patent (China)- ZL 200480040532.2 - Bioabsorbable Plug Implants and Method for Bone Tissue Regeneration, Granted 25th Aug 2010, Priority
filing: 22nd November 2004.
66. Patent - US 7968026 B1- Three-Dimensional Bioresorbable Scaffolds for Tissue Engineering Applications, Granted 28th Jun 2011, Priority
filing: 20th April 2004.
